Hidradenitis Suppurativa Medication: Prescription and OTC Options

Living with hidradenitis suppurativa (HS) means dealing with painful, recurring lumps and abscesses in sensitive areas, and finding the right hidradenitis suppurativa medication can be genuinely life-changing. Effective treatment ranges from over-the-counter washes and topical products for mild cases to powerful biologic drugs for severe, treatment-resistant disease. Because HS behaves differently from person to person, the right plan is one built with a dermatologist, not chosen from a list on your own.

Hidradenitis suppurativa is a chronic inflammatory skin condition that causes painful nodules, abscesses, and tunneling wounds (sinus tracts) in areas where skin rubs together, such as the armpits, groin, buttocks, and under the breasts. It is not caused by poor hygiene and it is not contagious. According to national health sources, HS affects an estimated 1 to 4 percent of people and is frequently underdiagnosed, with many patients waiting years for a correct diagnosis. While there is no cure, a growing set of medications can reduce flares, control pain, and help prevent the disease from progressing. For complementary information, visit our articles on hidradenitis suppurativa treatments and hidradenitis suppurativa surgery cost. You can also explore our medical conditions guide.

Important: This article is an educational overview and does not include drug doses on purpose. HS medications must be prescribed, dosed, and monitored by a qualified clinician who knows your history. Do not start, stop, or adjust any medication based on what you read here.

Understanding HS Severity Stages

Medication choices for HS are guided by disease severity, most commonly classified using the Hurley staging system:

• Hurley Stage I (Mild): Single or multiple isolated abscesses without sinus tracts or scarring. This stage is often most responsive to topical and oral medications.
• Hurley Stage II (Moderate): Recurrent abscesses with sinus tract formation and scarring in one or more areas. This stage frequently requires systemic medication and may benefit from a biologic.
• Hurley Stage III (Severe): Diffuse involvement with multiple interconnected sinus tracts, widespread scarring, and chronic drainage. Biologic therapy and surgical intervention are commonly needed.

Dermatology sources emphasize that early, consistent treatment can help prevent progression from mild to severe disease, which is why timely diagnosis and appropriate medication selection matter so much. Staging is also a moving target — a plan that works today may need to change as the disease evolves.

Topical Medications for Mild HS

For Hurley Stage I and milder Stage II disease, topical treatments are often a first line of therapy:

Topical Antibiotics

Clindamycin in a topical lotion or solution is a commonly prescribed topical antibiotic for HS. It is used to reduce bacterial colonization and inflammation on affected skin. Clinical studies have suggested that topical clindamycin can reduce the number of abscesses and nodules in mild disease compared with placebo. Your dermatologist will decide whether it fits your case and how to use it.

Antiseptic Washes

Chlorhexidine gluconate washes (such as Hibiclens) are frequently recommended as a daily cleanser for HS-affected areas to reduce bacterial load on the skin surface. Benzoyl peroxide washes are another option, though they can cause irritation and may bleach fabric. These are among the few HS measures available over the counter.

Topical Resorcinol

Resorcinol cream is a keratolytic (skin-exfoliating) agent that helps open blocked hair follicles, which is relevant because follicular occlusion is a key early event in HS. It is typically prescribed or compounded, and some studies report it can reduce the size, duration, and pain of individual lesions.

Oral Antibiotics

Oral antibiotics are a mainstay of HS treatment, used both for antibacterial effect and, importantly, for their anti-inflammatory properties:

First-Line Oral Antibiotics

• Tetracycline-class antibiotics: Doxycycline or minocycline are commonly used for defined courses. They provide anti-inflammatory benefits beyond their antibacterial effects and may reduce nodules and abscesses in mild to moderate HS.
• Clindamycin plus rifampin combination: This dual antibiotic regimen is one of the more established oral antibiotic combinations for HS, and studies report meaningful improvement in a substantial share of patients. It is prescribed and monitored by a clinician.

Second-Line Oral Antibiotics

• Rifampin, moxifloxacin, and metronidazole (triple therapy): Used for more resistant cases, this combination has shown promise in some studies but requires careful monitoring.
• Dapsone: An anti-inflammatory antibiotic that may help some patients, particularly those with neutrophilic inflammation.

It is important to understand that antibiotics in HS are used largely for their anti-inflammatory action rather than to treat an active bacterial infection. Long-term use raises concerns about antibiotic resistance, which is one reason clinicians tend to use defined treatment courses and reassess regularly.

Biologic Medications for Moderate to Severe HS

Biologic medications represent the most significant advance in HS treatment. These are injectable or intravenous drugs that target specific components of the immune system involved in HS inflammation. They are prescribed by specialists, require screening (including for tuberculosis) before starting, and involve ongoing monitoring.

FDA-Approved Biologics for HS

Adalimumab (Humira): The first biologic approved for HS in the United States (2015), adalimumab is a TNF-alpha inhibitor given by self-injection. Landmark clinical trials showed that a meaningful proportion of patients achieved at least a 50 percent reduction in inflammatory lesion count. Biosimilar versions of adalimumab are now available and may reduce cost.

Secukinumab (Cosentyx): An IL-17A inhibitor approved for moderate-to-severe HS in 2023, secukinumab offers a different mechanism of action for patients who do not respond adequately to TNF-alpha inhibitors. Trials showed improvement in inflammatory nodule and abscess counts compared with placebo.

Bimekizumab (Bimzelx): A newer biologic that blocks both IL-17A and IL-17F, bimekizumab became FDA-approved for moderate-to-severe HS in adults in 2024, making it the third biologic specifically approved for this condition. It expands the options for people whose disease is not well controlled by earlier therapies. As with all biologics, your dermatologist will weigh its benefits against risks such as infection.

Off-Label Biologics

• Infliximab (Remicade): Another TNF-alpha inhibitor given intravenously, often used off-label for severe HS when other options are insufficient. Some dermatologists consider it highly effective for HS, though head-to-head comparison data remain limited.
• Ustekinumab (Stelara): An IL-12/23 inhibitor with some evidence supporting off-label use in HS.
• Other investigational biologics: Additional agents targeting different inflammatory pathways continue to be studied for HS, including options such as spesolimab and others in ongoing trials. Ask your dermatologist whether a clinical trial might be appropriate for you.

Hormonal Therapies

Because HS often flares with hormonal changes and can be influenced by androgen hormones, hormonal therapies can be beneficial, particularly for women:

• Spironolactone: An anti-androgen medication that may reduce HS flares in women. It is generally not used in men because of feminizing effects.
• Combined oral contraceptives: Birth control pills containing anti-androgenic progestins may help control HS in some women.
• Metformin: Primarily a diabetes medication, metformin has anti-androgen and anti-inflammatory properties that may help some HS patients, particularly those with insulin resistance or polycystic ovary syndrome.
• Finasteride: A 5-alpha reductase inhibitor used off-label in selected cases, though the evidence base is limited.

Other Systemic Medications

Several additional systemic medications are used in HS management, always under specialist supervision:

• Retinoids (such as acitretin or isotretinoin): Oral retinoids can help reduce follicular plugging in some patients. They require careful monitoring because of side effects, and some are strictly contraindicated in pregnancy.
• Corticosteroids: Short courses of oral steroids may be used to calm a severe flare, and steroid injections directly into a painful lesion can quickly reduce inflammation. Long-term systemic steroid use is generally avoided.
• Colchicine: Traditionally used for gout, it has anti-inflammatory properties that may benefit some patients.
• Cyclosporine: An immunosuppressant that can help in refractory HS but is limited by side effects such as kidney effects and high blood pressure.

Pain Management and Wound Care

HS pain is real and can be significant. Pain management is an important part of care and may combine over-the-counter pain relievers, prescription options for severe pain, and treatment of the underlying inflammation. Good wound care — gentle cleansing, appropriate non-adherent dressings for draining lesions, and techniques to reduce friction — helps comfort and healing. A dermatologist or wound-care specialist can tailor this to your lesions; ask rather than improvising with harsh products that can worsen irritation.

Lifestyle Measures That Support Treatment

Medication works best alongside supportive lifestyle steps. Smoking cessation is one of the most impactful changes, as smoking is strongly associated with HS severity. Working toward a healthy weight may reduce friction and flares for some people. Wearing loose, breathable clothing, managing sweat, and avoiding skin trauma in affected areas can also help. These measures support, but do not replace, medical treatment.

Over-the-Counter Options and Supportive Care

Several OTC products can complement prescription hidradenitis suppurativa medication:

• Pain relief: Over-the-counter pain relievers such as ibuprofen or acetaminophen, used as directed on the label, for pain during flares.
• Warm compresses: Applied to lesions to ease discomfort and encourage natural drainage.
• Antiseptic washes: Chlorhexidine or benzoyl peroxide washes to help reduce bacterial colonization.
• Zinc supplements: Some evidence suggests zinc may reduce flare frequency for certain patients; discuss with your clinician before starting.
• Non-adherent wound dressings: For managing drainage from open lesions without sticking to the wound.
• Loose, breathable clothing: Reducing friction in affected areas may help prevent flares.

Never squeeze, pop, or cut into HS lesions yourself. Doing so can worsen inflammation, spread infection, and increase scarring. Drainage procedures should be done by a clinician.

Frequently Asked Questions

What is the most effective medication for HS?

The most effective medication depends on disease severity and how you respond. For mild HS, topical clindamycin combined with antiseptic washes is often enough. For moderate to severe HS, biologics — including the FDA-approved options adalimumab, secukinumab, and bimekizumab — have strong evidence, and the clindamycin-rifampin combination is a well-established oral antibiotic regimen. Treatment often means combining approaches rather than relying on a single drug, guided by a dermatologist.

How long does it take for HS medications to work?

Timelines vary. Topical antibiotics and antiseptic washes may show improvement over several weeks. Oral antibiotic combinations typically need a couple of months for full effect. Biologics may begin helping within weeks, but full benefit is often not clear until a few months in. Hormonal therapies can also take several months. Patience matters, and your dermatologist will assess response at set intervals and adjust the plan.

Can HS medication cause side effects?

All medications carry potential side effects. Topical clindamycin may irritate the skin. Oral antibiotics can cause stomach upset, and rifampin notably turns urine, tears, and sweat orange. Biologics can increase infection risk and require screening before starting. Hormonal therapies have their own considerations. Your dermatologist will discuss the specific risks and benefits of each option and monitor you with regular follow-up.

Is there a cure for hidradenitis suppurativa?

There is currently no cure for HS. It is a chronic condition that requires ongoing management. However, with the right combination of medications, lifestyle changes, and sometimes surgery, many people achieve meaningful control with fewer flares and better quality of life. Research into new treatments continues, which offers real reason for optimism.

Can I treat HS with over-the-counter products alone?

OTC antiseptic washes, warm compresses, and pain relievers can support your care, but HS is a medical condition that usually needs prescription treatment and a dermatologist’s guidance to control. Relying on OTC products alone often allows the disease to progress. Use them as a complement to, not a substitute for, professional care.

Sources

• Mayo Clinic — Hidradenitis suppurativa (symptoms, causes, and treatment)
• Cleveland Clinic — Hidradenitis Suppurativa
• American Academy of Dermatology (AAD) — Hidradenitis suppurativa: diagnosis and treatment
• MedlinePlus (U.S. National Library of Medicine) — Hidradenitis suppurativa
• U.S. Food & Drug Administration / DailyMed — Prescribing information for Humira (adalimumab), Cosentyx (secukinumab), and Bimzelx (bimekizumab)